Skip to main content

Aims and scope

Cardiovascular Diabetology considers manuscripts on all aspects of the diabetes/cardiovascular interrelationship and the metabolic syndrome; this includes clinical, genetic, experimental, pharmacological, epidemiological and molecular biology research.

© maurice norbert / Stock.adobe.comCardiovascular Diabetology appointed Dr. Pasquale Paolisso as Social Media Editor!
He will be selecting Cardiovascular Diabetology articles to be promoted on X each week based on highest quality of content and graphical abstract. Authors who want to promote their article in X are encouraged to tag Dr. Paolisso (@P_Paolisso) in their tweets.

Perivascular adipose tissue: friend or foe in cardiometabolic disorders

Edited by:
Dr. Cristina Sena, PhD, University of Coimbra, Portugal

Submission Status: Open until 31 January 2025

Call for Papers: Cardiometabolic HFpEF with focus on type 2 diabetes mellitus

Edited by:
Professor Francesco Paneni, MD, PhD, Department of Cardiology and CTEC, University Hospital and University of Zürich, Switzerland                         

Dr. Era Gorica, PhD, Department of Cardiology and CTEC, University Hospital and University of Zürich, Switzerland

Submission Status: Open until 20 November 2024


© Costantino, S., Mengozzi, A., Velagapudi, S. et al. Cardiovasc Diabetol 22, 312 (2023). Diabetology strongly encourages authors to submit a graphical abstract along with their manuscript. 
Articles with graphical abstracts will be prioritized for social media promotion. 

2023 Editor's highlights

Click here for a selection of 2023 highlight articles published in Cardiovascular Diabetology.

From the blog

New Content ItemContinuous glucose monitoring
2 November, 2023


New Content ItemTransforming diabetes management: the adoption of technology as a game changer in diabetes care
1 November, 2023

New Content ItemThe most effective medication for weight loss and blood glucose stabilization: Tirzepatide
11 January 2023

Announcing the launch of In Review

Cardiovascular Diabetology, in partnership with Research Square, is now offering In Review. Authors choosing this free optional service will be able to:

  • Share their work with fellow researchers to read, comment on, and cite even before publication
  • Showcase their work to funders and others with a citable DOI while it is still under review
  • Track their manuscript - including seeing when reviewers are invited, and when reports are received 

Editors' profiles

Professor Enrique Fisman graduated with a medical degree from Buenos Aires University, Argentina. Subsequently, he obtained the degree of Academic Cardiologist at the same university and worked several years at Carlos G. Durand Hospital in Buenos Aires. His research interests initially encompassed numerous fields of cardiology, with emphasis on Doppler and exercise echocardiography, estrogens and the heart, diagnostic expediency of dynamic and isometric stress testing, sports cardiology, epidemiology, hypertension, coronary calcification, computed tomography angiography, diagnostic and prognostic value of biomarkers, aortic blood flow velocity, and clinical pharmacology of antilipidemic agents. Since 1998, he focused mainly on the research of several experimental and clinical topics linked to the diabetes/cardiovascular interrelationship at Sheba Medical Center, Tel Hashomer, Israel. Professor Fisman is author or coauthor of more than 200 scientific publications, most of them original research articles. He is currently Professor Emeritus of Cardiology at Sackler Faculty of Medicine, Tel Aviv University, and Professor of Cardiology at the Specialization Career in Cardiology, del Salvador University (USAL), Buenos Aires.

Professor Alexander Tenenbaum graduated with a medical degree and a PhD in the former Soviet Union. He then became a cardiologist at the Sheba Medical Center, Tel Hashomer, Israel. Currently, he is the Scientific Director of the Cardiac Rehabilitation Institute, Sheba Medical Center, the Founder and Director of "Cardioline" Heart Institute and Professor of Cardiology at Tel Aviv University. His research interests and areas of expertise include clinical cardiology, echocardiography, hypertension, heart failure, cardiac rehabilitation, cardiovascular pharmacotherapy and computed tomography. During recent years he has become especially involved in the research of various aspects of dyslipidemia, metabolic syndrome, obesity and the diabetes/cardiovascular interrelationship. Prof. Tenenbaum is author or coauthor of hundreds scientific publications. He served as Governor of The International Society of Cardiovascular Pharmacotherapy and co-founder and Chairman of the Israel Heart Society Working Group on Cardiovascular Pharmacotherapy.

Editors' quotes

"Since the American Heart Association stated in 1999 that "diabetes is a cardiovascular disease", many revolutionary events took place in the rapidly evolving field of cardiovascular diabetology. The initial 'bridal' between heart diseases and diabetes is at present a vast and complex interdisciplinary texture which includes innovative biotechnological approaches, such as genomics, proteomics, metabolomics, molecular biometrics, bioinformatics, customized therapies and various additional sophisticated practices. Our journal endeavors to be a harbinger of these fascinating advances."

Professor Enrique Fisman, Editor-in-Chief, Cardiovascular Diabetology

"A strong correlation between cardiovascular disease and diabetes is now well established. The American Heart Association considers that individuals with insulin resistance or diabetes are more likely to fall victim to heart disease or stroke. Cardiovascular Diabetology is the world's foremost journal specifically devoted to this issue. Submitted manuscripts may report any aspect of laboratory, animal, or human research related to diabetes and its cardiovascular complications"

Professor Alexander Tenenbaum, Editor-in-Chief (2002-2021), Cardiovascular Diabetology

Cardiovascular Diabetology is affiliated with Sackler Faculty of Medicine, Tel-Aviv University

New Content Item

Annual Journal Metrics

  • Citation Impact 2023
    Journal Impact Factor: 8.5
    5-year Journal Impact Factor: 8.9
    Source Normalized Impact per Paper (SNIP): 1.855
    SCImago Journal Rank (SJR): 2.621

    Speed 2023
    Submission to first editorial decision (median days): 2
    Submission to acceptance (median days): 56

    Usage 2023
    Downloads: 2,523,778
    Altmetric mentions: 3,115